Skip to main content

Table 3 Characteristics and outcomes of patients with spontaneous bacterial peritonitis due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species (ESBL-EK), according to the effectiveness of the initial therapy

From: Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellaspecies: A retrospective matched case-control study

Characteristics

Initial therapy

P-value

 

Effective (n = 8)

Ineffective (n = 18)

 

   Age (mean in year, SD)

62.1 ± 9.3

58.3 ± 10.4

0.363

   Male (n, %)

4 (50%)

15 (83%)

0.149

   Escherichia coli (n, %)

5 (63%)

12 (67%)

1.000

   Child-Pugh score (mean, SD)

10.4 ± 1.6

11.1 ± 1.6

0.330

   APACHE II score (mean, SD)

15.6 ± 3.8

15.6 ± 3.7

0.993

Outcomes

   

   Initial response

   

Complete response (n, %)

1 (13%)

1 (6%)

0.529

Treatment failure (n, %)

2 (25%)

13 (72%)

0.038

   7-day mortality (n, %)

1 (13%)

8 (44%)

0.190

   30-day mortality (n, %)

1 (13%)

11 (61%)

0.036

  1. SD – standard deviation
  2. APACHE II – Acute Physiologic and Chronic Health Evaluation II
  3. Initial response was assessed 72 hours after the initiation of empirical treatment